Financials
- Market Capitalization 668.01 M
- Employee 121
- Founded 2013
- CEO N/A
- Website www.solidbio.com
- Headquarter Delaware, United States
- FIGI BBG00JN4FXG8
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-2.83
Fiyat/satışlar oranı
530.1
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 2650 | AVTX Avalo Therapeutics, Inc. - Common Stock | 12.70 USD | -4.08% | -7.30% | -22.70% | -6.55% | 681.10 M USD | ||
| 2659 | PHAR Pharming Group N.V. - ADS, each representing 10 | 9.57 USD | -0.42% | -1.75% | -11.22% | -34.68% | 671.51 M USD | ||
| 2665 | AURA Aura Biosciences, Inc. - Common Stock | 6.42 USD | -1.83% | +3.05% | -8.94% | +5.25% | 665.78 M USD | ||
| 2686 | ZVRA Zevra Therapeutics, Inc. - Common Stock | 10.60 USD | -6.36% | -1.03% | -11.89% | -0.38% | 629.47 M USD |